← Leaderboards
Antonio Sanz-Clemente
Northwestern University At Chicago
$3,137,639
Attributed
$3,137,639
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $492.7K · FY2015–24$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,137,639 · 2
By mechanism
R01$2,390,639 · 1
R00$747,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Pembe Hande Ozdinler$5,138,990
- Charles Anderson$2,707,081
- Xin Tong$357,545
- David J. Escobar$70,376
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposSynaptic PlasticityFunctional DisorderEquilibriumS DiseaseSynapsesLigandsMolecularN-Methyl-D-Aspartate ReceptorsTraffickingProteinsRegulationEventSitePostsynapticGlutamate ReceptorBiochemistryLinkCasein Kinase IiNeurodegenerative DisordersPhosphorylationPathologicPharmacologyDensity
Grant awards (8)
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations$468,685
R01 · FY2024 · AG · contact PI
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations$468,685
R01 · FY2023 · AG · contact PI
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations$468,685
R01 · FY2022 · AG · contact PI
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations$491,840
R01 · FY2021 · AG · contact PI
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations$492,744
R01 · FY2020 · AG · contact PI
Role of CK2 in NMDAR trafficking during development and in Alzheimer's disease$249,000
R00 · FY2017 · AG · contact PI
Role of CK2 in NMDAR trafficking during development and in Alzheimer's disease$249,000
R00 · FY2016 · AG · contact PI
Role of CK2 in NMDAR trafficking during development and in Alzheimer's disease$249,000
R00 · FY2015 · AG · contact PI